SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-18-000215
Filing Date
2018-01-02
Accepted
2018-01-02 16:10:29
Documents
2
Group Members
FCPI INNOVEN CAPITAL 2FCPI INNOVEN EUROPEFCPI INNOVEN EUROPE 2FCPI LA BANQUE POSTALE INNOVATION 1FCPI POSTE INNOVATIONFCPI POSTE INNOVATION 2FCPI POSTE INNOVATION 3FCPI POSTE INNOVATION 5FCPI POSTE INNOVATION 6JEAN-MICHEL PAULHAC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 tv482437_sc13da.htm SC 13D/A 171966
2 EXHIBIT 1 tv482437_ex1.htm EX-1 11618
  Complete submission text file 0001144204-18-000215.txt   185539
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Subject) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88748 | Film No.: 18501864
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BURNS & LEVINSON LLP 125 SUMMER STREET BOSTON MA 02110
Business Address C/O BURNS & LEVINSON LLP 125 SUMMER STREET BOSTON MA 02110 617-345-3000
IPSA (INNOVEN PARTENAIRES S.A.) (Filed by) CIK: 0001620376 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13D/A